Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$161.02 - $206.98 $42.6 Million - $54.8 Million
-264,853 Reduced 93.39%
18,750 $3.78 Million
Q1 2024

May 14, 2024

BUY
$163.6 - $209.11 $46.2 Million - $59 Million
282,315 Added 21918.87%
283,603 $48.6 Million
Q4 2023

Feb 13, 2024

SELL
$127.77 - $221.42 $49.2 Million - $85.3 Million
-385,399 Reduced 99.67%
1,288 $279,000
Q3 2023

Nov 13, 2023

BUY
$154.67 - $290.89 $41.5 Million - $78.1 Million
268,553 Added 227.33%
386,687 $61.7 Million
Q2 2023

Aug 14, 2023

SELL
$272.48 - $330.23 $2.72 Million - $3.29 Million
-9,975 Reduced 7.79%
118,134 $34.1 Million
Q1 2023

May 15, 2023

BUY
$276.36 - $326.03 $26.5 Million - $31.2 Million
95,850 Added 297.13%
128,109 $40.9 Million
Q4 2022

Feb 14, 2023

BUY
$212.22 - $313.46 $6.85 Million - $10.1 Million
32,259 New
32,259 $9.5 Million
Q1 2022

May 09, 2022

SELL
$194.8 - $275.7 $3.46 Million - $4.9 Million
-17,769 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$255.32 - $318.29 $4.54 Million - $5.66 Million
17,769 New
17,769 $4.73 Million
Q3 2021

Nov 12, 2021

SELL
$260.36 - $307.27 $365,545 - $431,407
-1,404 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$225.52 - $304.06 $316,630 - $426,900
1,404 New
1,404 $385,000
Q1 2021

May 14, 2021

SELL
$235.95 - $293.05 $440,046 - $546,538
-1,865 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$215.97 - $265.89 $4.32 Million - $5.32 Million
-20,009 Reduced 91.47%
1,865 $477,000
Q3 2020

Nov 12, 2020

BUY
$192.55 - $236.59 $3.85 Million - $4.72 Million
19,970 Added 1048.84%
21,874 $5.18 Million
Q2 2020

Aug 14, 2020

SELL
$159.17 - $224.73 $624,742 - $882,065
-3,925 Reduced 67.34%
1,904 $370,000
Q1 2020

May 15, 2020

BUY
$130.01 - $216.44 $757,828 - $1.26 Million
5,829 New
5,829 $966,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.